⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 24, 2004Cardiovascular Research

Negative regulators of cardiac hypertrophy

View Full Paper

Ask AI

Bookmark

Share

Design

Review

Authors

SHStefan E. HardtUniversity of Siena

Discussion

Loading...

Member takes

Implication

May inform HF therapies via hypertrophy regulators; leaves open clinical translation pending prospective validation.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Stefan E. Hardt (2004) studied this question.

synapsesocial.com/papers/6a7c1bd2f056b38aaddf8a8b https://doi.org/10.1016/j.cardiores.2004.03.015

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Peroxisome Proliferator Activated Receptor (PPAR)α Agonists Inhibit Hypertrophy of Neonatal Rat Cardiac Myocytes2003 · 76 citations
2Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy <i>in vivo</i>2001 · 295 citations
3Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes.2001 · 194 citations
4Targeted Inhibition of Calcineurin in Pressure-overload Cardiac Hypertrophy2002 · 122 citations
5RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overload1999 · 200 citations